Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18
Published January 31, 2024 · Recall initiated: December 21, 2023
Summary
FDA records drug Class I recall D-0261-2024, published January 31, 2024 and initiated December 21, 2023. Recalling firm: PFIZER; Status: Ongoing; Reported quantity: 3,546 vials; Lot: Lot #: BL12206A, Exp date 06/30/2024. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of particulate matter: glass
What to do
Voluntary: Firm initiated · Press Release
Get an email if BLEOMYCIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BLEOMYCIN
- Manufacturer
- PFIZER
- Distributor
- Nationwide in the USA, Netherlands and Libya
- Lot
- Lot #: BL12206A, Exp date 06/30/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMethoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd.January 31, 2024
- FDAFosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only afterJanuary 31, 2024
- FDAFluocinolone Acetonide Oil, 0.01% (Ear Drops), package in 1 Oz. (20 mL fill volume) bottle, Rx only,January 31, 2024
- FDACinacalcet Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc.,January 31, 2024
- FDAVasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis,January 31, 2024
- FDAFebuxostat Tablets 40mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc.,January 31, 2024
Questions about this recall
Was Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18 recalled?
Yes. FDA published recall D-0261-2024 on January 31, 2024. Reported hazard: Presence of particulate matter: glass
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BLEOMYCIN.